November 16th 2021
AHA 2021. Heart failure patients, across ejection fraction and diabetes status, reported improved QOL as early as 3 months in CHIEF-HF trial.
November 16th 2021
AHA 2021: Study suggests remote hypertension and hyperlipidemia management programs may expand telehealth delivery, increase access to care, and reduce health inequities.
November 15th 2021
AHA 2021: Novel software algorithm used in Fitbit wearable devices accurately detected undiagnosed atrial fibrillation about 98% of the time, showed results of the Fitbit Heart Study.
November 15th 2021
AHA 2021. Coffee increased PVCs by 54% in regular coffee drinkers and decreased sleep by more than 30 minutes; it also significantly increased daily step count and slightly improved SVT.
November 12th 2021
AHA Scientific Sessions 2021: New research provides a note of caution for the use of digital heart failure coaching apps in severely ill and elderly patients with unstable heart failure.
November 12th 2021
AHA Scientific Sessions 2021: Employment status and higher caregiver burden were linked to increased engagement with a videoconferencing-based intervention to reduce the risk of CVD.
November 12th 2021
EHR-integrated remote BP monitoring was evaluated in a primary care Medicare population to assess uptake and initial effects on hypertension management.
November 10th 2021
AHA Scientific Sessions 2021. Statin-associated muscle symptoms complicate treatment initiation and adherence; a new mHealth tool shows promise in reducing treatment cessation.
November 10th 2021
AHA Scientific Sessions 2021: Blood pressure reductions to clinical targets were achieved by patients with sustained hypertension through a remote health care delivery program during the COVID-19 pandemic.
November 9th 2021
AHA Scientific Sessions 2021: New research found living in socially vulnerable neighborhoods increased the risk of myocardial infarction, stroke, or death among hospitalized COVID-19 patients.